Asklepios BioPharmaceutical, Inc. (AskBio) is a leading gene therapy company focused on developing treatments for debilitating genetic diseases. Wholly owned by Bayer AG, AskBio specializes in adeno-associated virus (AAV)-based gene therapies aimed at treating various neuromuscular, central nervous system, cardiovascular, and metabolic diseases. One of their notable developments is AB-1003 (LION-101), which has received FDA rare pediatric disease and orphan-drug designations for treating limb-girdle muscular dystrophy type 2I/R9. AskBio is dedicated to advancing genetic medicine, with a robust portfolio of clinical programs designed to bring innovative therapeutic options to patients worldwide.
AAV β’ Adeno-Associated Virus β’ Gene Therapy β’ Rare Disease β’ AAV Manufacturing
December 4, 2024
501 - 1000
𧬠Biotechnology
π Pharmaceuticals
βοΈ Healthcare Insurance
Manager driving sales growth for Viralgen's AAV manufacturing services, executing go-to-market strategies.
November 26, 2024
501 - 1000
𧬠Biotechnology
π Pharmaceuticals
βοΈ Healthcare Insurance
Manage sales growth and strategy for AAV manufacturing services in a remote position. Coordinate with executives and lead negotiations for client agreements.
November 26, 2024
501 - 1000
𧬠Biotechnology
π Pharmaceuticals
βοΈ Healthcare Insurance
Lead sales growth strategies for AAV manufacturing services at Viralgen Vector Core. Manage client relations and sales process in a remote role.